Tumor flare with T-cell-engaging bispecific antibodies

Affiliations

• ¹ Department of Biochemical Sciences, Humanitas University, Rozzano, Milano, Italy.
• ² Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy.
• ³ PeterMacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, Victoria, Australia.
• ⁴ Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Campus, Barcelona, Spain.
• ⁵ Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
• ⁶ Roche Products Ltd, Welwyn Garden City, United Kingdom.
• ⁷ Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany.
• ⁸ Product Development Safety, Genentech, Inc., South San Francisco, CA, USA.
• ⁹ Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.